Ovixan 1 mg/g kutan lösning

Ovixan is a potent corticosteroid solution containing mometasone furoate, primarily used for treating inflammatory skin conditions such as psoriasis and eczema. The product was developed by the Swedish pharmaceutical company Galenica AB, which is headquartered in Malmö.

While Galenica holds the marketing authorization and developed the formulation, the physical manufacturing is carried out by specialized contract manufacturing organizations. Production typically takes place in facilities such as Laboratorio Reig Jofré S.A. in Spain or Lichtenheldt GmbH in Germany. The brand is widely distributed across the Nordic regions, including Sweden, Finland, and Iceland, under the same name or slight variations like Ovison.